1. Home
  2. CPHI vs DFLI Comparison

CPHI vs DFLI Comparison

Compare CPHI & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • DFLI
  • Stock Information
  • Founded
  • CPHI N/A
  • DFLI 2020
  • Country
  • CPHI China
  • DFLI United States
  • Employees
  • CPHI N/A
  • DFLI N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • CPHI Health Care
  • DFLI Technology
  • Exchange
  • CPHI Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • CPHI 5.4M
  • DFLI 5.0M
  • IPO Year
  • CPHI N/A
  • DFLI N/A
  • Fundamental
  • Price
  • CPHI $2.22
  • DFLI $0.40
  • Analyst Decision
  • CPHI
  • DFLI Strong Buy
  • Analyst Count
  • CPHI 0
  • DFLI 2
  • Target Price
  • CPHI N/A
  • DFLI $8.63
  • AVG Volume (30 Days)
  • CPHI 85.3K
  • DFLI 413.5K
  • Earning Date
  • CPHI 05-23-2025
  • DFLI 05-15-2025
  • Dividend Yield
  • CPHI N/A
  • DFLI N/A
  • EPS Growth
  • CPHI N/A
  • DFLI N/A
  • EPS
  • CPHI N/A
  • DFLI N/A
  • Revenue
  • CPHI $4,295,377.00
  • DFLI $50,645,000.00
  • Revenue This Year
  • CPHI N/A
  • DFLI $42.48
  • Revenue Next Year
  • CPHI N/A
  • DFLI $42.95
  • P/E Ratio
  • CPHI N/A
  • DFLI N/A
  • Revenue Growth
  • CPHI N/A
  • DFLI N/A
  • 52 Week Low
  • CPHI $1.20
  • DFLI $0.46
  • 52 Week High
  • CPHI $4.10
  • DFLI $13.14
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 56.97
  • DFLI 28.02
  • Support Level
  • CPHI $2.08
  • DFLI $0.34
  • Resistance Level
  • CPHI $2.50
  • DFLI $0.52
  • Average True Range (ATR)
  • CPHI 0.23
  • DFLI 0.07
  • MACD
  • CPHI 0.06
  • DFLI 0.01
  • Stochastic Oscillator
  • CPHI 63.64
  • DFLI 18.80

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: